NovaBay Pharmaceuticals, Inc. Depreciation & Amortization Growth

Depreciation & Amortization Growth of NBY for past 10 years: annual, quarterly and twelve month trailing (TTM) including Depreciation & Amortization Growth growth rates and interactive chart.


Highlights and Quick Summary

  • Depreciation & Amortization Growth for the quarter ending September 30, 2022 was 891.67% (a -10.02% decrease compared to previous quarter)
  • Year-over-year quarterly Depreciation & Amortization Growth increased by 29.06%
  • Annual Depreciation & Amortization Growth for 2021 was 133.33% (a -718.99% decrease from previous year)
  • Annual Depreciation & Amortization Growth for 2020 was -21.54% (a -71.49% decrease from previous year)
  • Annual Depreciation & Amortization Growth for 2019 was -75.56% (a -141.98% decrease from previous year)
  • Twelve month Depreciation & Amortization Growth ending September 30, 2022 was 939.53% (a 36.03% increase compared to previous quarter)
  • Twelve month trailing Depreciation & Amortization Growth increased by 604.67% year-over-year
Trailing Depreciation & Amortization Growth for the last four month:
30 Sep '22 30 Jun '22 31 Mar '22 31 Dec '21
939.53% 690.7% 402.17% 133.33%
Visit stockrow.com/NBY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Depreciation & Amortization Growth of NovaBay Pharmaceuticals, Inc.

Most recent Depreciation & Amortization Growthof NBY including historical data for past 10 years.

Interactive Chart of Depreciation & Amortization Growth of NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals, Inc. Depreciation & Amortization Growth for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 891.67% 990.91% 1244.44%
2021 690.91% 0.0% -21.43% -35.71% 133.33%
2020 -26.67% 104.6% -95.24% -17.65% -21.54%
2019 -68.09% -383.7% 241.86% -58.54% -75.56%
2018 14.63% 411.11% 377.78% 127.78% 180.0%
2017 156.25% -41.94% -33.33% -55.0% -16.67%
2016 -60.98% -24.39% -34.15% -2.44% -30.49%
2015 -12.77% -6.82% -42.25% -41.43% -29.31%
2014 -36.49% -44.3% -11.25% -13.58% -26.11%
2013 -12.94% -3.66% -3.61% -10.99% -7.92%
2012 -18.27% -21.9% -23.85% -14.95% -19.76%
2011 -11.86% -2.75%

Business Profile of NovaBay Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology